A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular CarcinomaWinnie Yeo, Philip J. Johnson, Kwok Chi Lam et al.|JNCI Journal of the National Cancer Institute|2005Cited by 591
TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistanceNathalie Wong, Ka‐Fai To, Winnie Yeo et al.|International Journal of Cancer|2008Cited by 196
Quality of life is predictive of survival in patients with unresectable hepatocellular carcinomaWinnie Yeo, Benny Zee, Frankie Mo et al.|Annals of Oncology|2006Cited by 121
Liver Resection after Irinotecan, 5-Fluorouracil, and Folinic Acid for Patients with Unresectable Colorectal Liver Metastases: A Multicenter Phase II Study by the Cancer Therapeutic Research GroupWing Ming Ho, Anthony T.�C. Chan, Brigette Ma et al.|Medical Oncology|2005Cited by 56
Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma – clinical application of health-related quality-of-life dataLeung Li, Winnie Yeo, Frankie Mo et al.|BMC Cancer|2017Cited by 53